share_log

安旭生物(688075.SH)：2023年净利润预减94.98%到95.82%

Anxu Biotech (688075.SH): 2023 net profit pre-reduced by 94.98% to 95.82%

Gelonghui Finance ·  Jan 30 03:54

Gelonghui, January 30丨An Xu Biotech (688075.SH) announced its 2023 annual results forecast. According to preliminary estimates by the finance department, it is expected to achieve net profit of 127.3982 million yuan to 152.887 million yuan in 2023. Compared with the same period last year (statutory disclosure data), it will decrease 2891.754 million yuan to 2917.2751 million yuan, a year-on-year decrease of 94.98% to 95.82%. Net profit attributable to the owner of the parent company is expected to be 52.0931 million yuan to 62,511,17 million yuan in 2023. Compared with the same period of the previous year (statutory disclosure data), it will decrease by 292,1026,700 yuan to 2931.4.53 million yuan, a year-on-year decrease of 97.90% to 98.25%.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment